4
Changes in Ownership
Amylyx Pharmaceuticals, Inc. Filed Acc 0000899243-23-001517
Co-Chief Executive Officer sold 5,968 shares at an average $36.30 ($216,629)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Klee Justin B. Co-Chief Executive Officer | 2023-01-06 | Sale | +4,122 | $36.08 | $148,717 | 2,894,463 | D |
| Klee Justin B. Co-Chief Executive Officer | 2023-01-06 | Sale | +1,846 | $36.79 | $67,912 | 2,892,617 | D |
| Open-market sales · 5,968 sh · avg $36.30 · $216,629 | |||||||
Loading xslF345X03/doc4.xml…